Cargando…
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
BACKGROUND: The internet portal http://www.brustkrebs-studien.de (BKS) was launched in 2000 by the German Society of Senology (DGS) and the Baden-Württemberg Institute for Women's Health (IFG) to provide expert-written information on breast cancer online and to encourage and facilitate the part...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016291/ https://www.ncbi.nlm.nih.gov/pubmed/21126358 http://dx.doi.org/10.1186/1471-2407-10-663 |
_version_ | 1782195713189347328 |
---|---|
author | Wallwiener, Markus Wallwiener, Christian W Brucker, Sara Y Hartkopf, Andreas D Fehm, Tanja N Kansy, Julia K |
author_facet | Wallwiener, Markus Wallwiener, Christian W Brucker, Sara Y Hartkopf, Andreas D Fehm, Tanja N Kansy, Julia K |
author_sort | Wallwiener, Markus |
collection | PubMed |
description | BACKGROUND: The internet portal http://www.brustkrebs-studien.de (BKS) was launched in 2000 by the German Society of Senology (DGS) and the Baden-Württemberg Institute for Women's Health (IFG) to provide expert-written information on breast cancer online and to encourage and facilitate the participation of breast cancer patients in clinical trials. We describe the development of BKS and its applications, and report on website statistics and user acceptance. METHODS: Existing registries, including ClinicalTrials.gov, were analysed before we designed BKS, which combines a trial registry, a knowledge portal, and an online second opinion service. An advisory board guided the process. Log files and patient enquiries for trial participation and second opinions were analysed. A two-week user satisfaction survey was conducted online. RESULTS: During 10/2005-06/2010, the portal attracted 702,655 visitors, generating 15,507,454 page views. By 06/2010, the website's active scientific community consisted of 189 investigators and physicians, and the registry covered 163 clinical trial protocols. In 2009, 143 patients requested trial enrolment and 119 sought second opinions or individual treatment advice from the expert panel. During the two-week survey in 2008, 5,702 BKS visitors submitted 507 evaluable questionnaires. Portal acceptance was high. Respondents trusted information correctness (80%), welcomed self-matching to clinical trials (79%) and planned to use the portal in the future (76%) and recommend it to others (81%). CONCLUSIONS: BKS is an established and trusted breast cancer information platform offering up-to-date resources and protocols to the growing physician and patient community to encourage participation in clinical trials. Further studies are needed to assess potential increases in trial enrolment by eligibility matching services. |
format | Text |
id | pubmed-3016291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30162912011-01-06 The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service Wallwiener, Markus Wallwiener, Christian W Brucker, Sara Y Hartkopf, Andreas D Fehm, Tanja N Kansy, Julia K BMC Cancer Research Article BACKGROUND: The internet portal http://www.brustkrebs-studien.de (BKS) was launched in 2000 by the German Society of Senology (DGS) and the Baden-Württemberg Institute for Women's Health (IFG) to provide expert-written information on breast cancer online and to encourage and facilitate the participation of breast cancer patients in clinical trials. We describe the development of BKS and its applications, and report on website statistics and user acceptance. METHODS: Existing registries, including ClinicalTrials.gov, were analysed before we designed BKS, which combines a trial registry, a knowledge portal, and an online second opinion service. An advisory board guided the process. Log files and patient enquiries for trial participation and second opinions were analysed. A two-week user satisfaction survey was conducted online. RESULTS: During 10/2005-06/2010, the portal attracted 702,655 visitors, generating 15,507,454 page views. By 06/2010, the website's active scientific community consisted of 189 investigators and physicians, and the registry covered 163 clinical trial protocols. In 2009, 143 patients requested trial enrolment and 119 sought second opinions or individual treatment advice from the expert panel. During the two-week survey in 2008, 5,702 BKS visitors submitted 507 evaluable questionnaires. Portal acceptance was high. Respondents trusted information correctness (80%), welcomed self-matching to clinical trials (79%) and planned to use the portal in the future (76%) and recommend it to others (81%). CONCLUSIONS: BKS is an established and trusted breast cancer information platform offering up-to-date resources and protocols to the growing physician and patient community to encourage participation in clinical trials. Further studies are needed to assess potential increases in trial enrolment by eligibility matching services. BioMed Central 2010-12-02 /pmc/articles/PMC3016291/ /pubmed/21126358 http://dx.doi.org/10.1186/1471-2407-10-663 Text en Copyright ©2010 Wallwiener et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wallwiener, Markus Wallwiener, Christian W Brucker, Sara Y Hartkopf, Andreas D Fehm, Tanja N Kansy, Julia K The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title | The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title_full | The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title_fullStr | The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title_full_unstemmed | The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title_short | The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service |
title_sort | brustkrebs-studien.de website for breast cancer patients: user acceptance of a german internet portal offering information on the disease and treatment options, and a clinical trials matching service |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016291/ https://www.ncbi.nlm.nih.gov/pubmed/21126358 http://dx.doi.org/10.1186/1471-2407-10-663 |
work_keys_str_mv | AT wallwienermarkus thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT wallwienerchristianw thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT bruckersaray thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT hartkopfandreasd thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT fehmtanjan thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT kansyjuliak thebrustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT wallwienermarkus brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT wallwienerchristianw brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT bruckersaray brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT hartkopfandreasd brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT fehmtanjan brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice AT kansyjuliak brustkrebsstudiendewebsiteforbreastcancerpatientsuseracceptanceofagermaninternetportalofferinginformationonthediseaseandtreatmentoptionsandaclinicaltrialsmatchingservice |